dihexa human studies clinical trials or dihexa human clinical trials or studies dihexa clinical trials status dihexa human trials status 2026 SCOPE Dihexa 10mg × 60 capsules

This synergistic formulation targets several hallmarks of aging (chronic inflammation, oxidative stress, vascular decline, and collagen loss) to promote youthful structural integrity and enhanced cellular function 1 -5

Sikiric P, Gojkovic S, Krezic I, Smoday IM, Kalogjera L, Zizek H, Oroz K, Vranes H, Vukovic V, Labidi M, Strbe S, Baketic Oreskovic L, Sever M, Tepes M, Knezevic M, Barisic I, Blagaic V, Vlainic J, Dobric I, Staresinic M, Skrtic A, Jurjevic I, Boban Blagaic A, Seiwerth S

showed that dual blockade of SU11274 (c-MET inhibitor) and erlotinib (EGFR inhibitor) in HNSCC lines produce greater-than-additive inhibition of cell growth via erbB3/AKT signaling [86]

Advantage : CagriSema Weight Loss Efficacy# CagriSema : REDEFINE 1 demonstrated 20.4% mean weight loss at 68 weeks in adults without T2D